Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
148.5 USD | -0.54% | +1.06% | -5.33% |
01:06pm | J&J: encouraging results in prostate cancer | CF |
12:26pm | J&J: positive results in bladder cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.33% | 359B | |
+31.26% | 662B | |
+21.96% | 546B | |
+16.97% | 323B | |
+4.71% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.04% | 167B | |
-2.19% | 157B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Johnson & Johnson Forecasts COVID-19 Vaccine Sales Of Up To $3.5 Billion In 2022